Welcome to rPeptide

We provide high quality Peptide, Reagents, Proteins, Antibodies,
and more, with a focus on Alzheimer’s and Parkinson’s disease research.
Our proprietary platform vector technology enables the recombinant expression
of historically difficult peptides/ proteins as soluble peptides/ proteins in E. coli.
We offer a large selection of Beta Amyloids, Taus, Synucleins, Calmodulins, Custom Products and more.

ORDER ONLINE  •  CALL 866.753.0747  •  FAX 678.753.0746

Faster Ordering

We now offer expedited online ordering options:

  • Save your cart for later
  • Quickly reorder previous orders
  • Calculate all costs in your shopping cart

Sign In or Register to get started.

rPeptide Citations

March 2014 — Published: March 05, 2014, DOI: 10.1371/journal.pone.0090610: Modulation of RNase E Activity by Alternative RNA Binding Sites | Other Products

March 2014 — Molecular and Cellular Therapies 2014, 2 :7 doi:10.1186/2052-8426-2-7: microRNA therapies in cancer | Other Products

March 2014 — Received 27 Jan, 2014. Accepted 09 Mar, 2014. First published online 10 Mar, 2014: Electrochemical protein-based biosensor for detection of tau protein, a neurodegenerative disease biomarker | Tau Products

February 2014 — DOI: 10.1021/ml400489b: Predicting the Reactivity of Nitrile-Carrying Compounds with Cysteine: A Combined Computational and Experimental Study | Other Products

February 2014 — DOI 10.1007/s00401-014-1256-4: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials | Synuclein Products

February 2014 — DOI: 10.1111/bpa.12130: Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies | Synuclein Products

January 2014 — United States Patent Application 20140005240: COMPOUNDS AND COMPOSITIONS FOR USE AS MODULATORS OF TAU AGGREGATION AND ALLEVIATION OF TAUOPATHIES | Tau Products

January 2014 — Mol. Pharmaceutics, Just Accepted Manuscript DOI: 10.1021/mp400230s Publication Date (Web): January 31, 2014 Copyright © 2014 American Chemical Society: Towards a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assay. | Other Products

January 2014 — United States Patent Application 20140010809 Kind Code: A1: BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS | Other Products

January 2014 — Submission date 24 April 2013 Acceptance date 14 January 2014 Publication date 21 January 2014: Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy | Other Products

January 2014 — Copyright © 2014 Elsevier B.V. except certain content provided by third parties. ScienceDirect® is a registered trademark of Elsevier B.V.: “Structural characterization of the minimal segment of TDP-43 competent for aggregation” | Other Products

January 2014 — Posted online on January 3, 2014. (doi:10.1517/13543776.2014.863874) Read More: http://informahealthcare.com/doi/abs/10.1517/13543776.2014.863874: Peptide nucleic acids: a review on recent patents and technology transfer Read More: http://informahealthcare.com/doi/abs/10.1517/13543776.2014.863874 | Other Products

January 2014 — 1Laboratory of Morphogenesis, Center of Advanced Study in Botany, Banaras Hindu University, Varanasi-221005, India 2Molecular Biology Section, Laboratory of Algal Biology, Center of Advanced Study in Botany, Banaras Hindu University, Varanasi-221005, India.: Enhanced photosynthesis and Carbon metabolism favor Arsenic tolerance in Artemisia annua, a medicinal plant as revealed by homology-based Proteomics | Other Products

February 2013 — Experimental Neurology: Changes in Properties of Serine 129 Phosphorylated α-Synuclein with Progression of Lewy Type Histopathology in Human Brains | Synuclein Products

January 2013 — J. Neurochem: Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and transgenic mice expressing the disease-causing A30P mutation. | Tau Products

January 2013 — Biochemistry,: Elevated Copper Binding Strength of Amyloid-β Aggregates Enables Their Copper Sequestration from Albumin: a Pathway to Accumulation of Copper in Senile Plaques. | Beta Amyloid Products

January 2013 — PLoS ONE: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease | Beta Amyloid Products

January 2013 — Molecular Genetics and Metabolism: Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. | Synuclein Products

September 2012 — Journal of Alzheimer's Disease: Methods for Measuring Tau Pathology in Transgenic Mouse Models | Tau Products

September 2012 — Int Immunopharmacol: Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity | Synuclein Products

July 2012 — Journal of Alzheimer's Disease: Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression | Synuclein Products

July 2012 — FEBS Letters: Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis | Synuclein Products